According to the chief scientist of the Pfizer strike, the first coronavirus vaccine for children may be approved in June.
Pfizer has already introduced a modified dose of the vaccine for the approval of children over the age of 12 in the United States, and plans to present it next week to the European Medicines Agency (EMA) in the European Union.
“Everything can move very fast now,” said Professor ահahin, CEO and founder of BioNTech, a German company that developed the Pfizer vaccine. Spiegel: magazine.
“It is very possible to give children the opportunity to go back to everyday school life, to meet family and friends.”
Professor Sahin said U.S. test studies have shown that the vaccine is well tolerated in children 12 և older and elicits a high antibody response, offering 100% protection against Covid-19.
“These promising results show that children are particularly well protected with the vaccine,” he said.
Although the vaccine is currently only approved for adults in the UK և EU, it has been approved in the US since the age of 16.
BioNTech has already introduced a new version of the approval of children over the age of 12 in the US և hopes to present it to the EMA early next Wednesday.
There is not a single day that Pfizer plans to submit it to the Drug Enforcement Agency (MHRA) in the UK, but it is expected in the coming weeks.
The approval process usually takes a few weeks, և if all goes smoothly, children can be given the first blows in the US և EU before June.
However, confirmation is not guaranteed. Testing is especially strict before vaccines are approved for children who may respond differently as their bodies develop.
The manufacturers of all four currently approved vaccines in the EU, Pfizer, Moderna, AstraZeneca և Johnson & Johnson, have agreed on plans for extensive testing that will be required before children can be approved.
Vaccines are usually carefully adjusted for age, and children over 12 years of age should be monitored before giving them to young children.
Trials of the Pfizer vaccine have already been performed in young children, with preliminary results expected in the 5-12 age group in July and in children aged six months to four years in September.
“If all goes well, once the data is evaluated, we can apply for the vaccine for children of the appropriate age group,” said Professor ինըahin.
The Pfizer vaccine was first approved in the United Kingdom, the United States, and the EU, and Professor ինըahin and his wife, Ozlem Türeci, who also worked on it, were recognized as heroes in Germany.
Both of Turkish origin. Professor ինըahin was born in Turkey and moved to Germany at the age of four, where they were presented as a success story for immigrants.
In January, a few weeks after the adult vaccine was approved, Professor ինըahin and Dr. Tyurets set a new goal for their team to develop and test a safe vaccine for children next winter.
Although herd immunity in adults may be sufficient to contain the virus, Professor Sahin was concerned about the risk of developing a dangerous variant for children.
Recent studies in Germany suggest that children may have long-term psychological effects from coronavirus blockade.
A study by the University of Hamburg found that a third of children aged 11-17 suffer from depression during closure, and 44% suffer from insomnia.